Life science current events this week include Biotech 2011 panel highlights mistakes of new medical product launches, Cleveland Clinic no longer reports hospital-acquired infections to nonprofit patient group, and Minnesota launches group deals site for Celiac disease sufferers.
So, you not only come up with a great medical device or drug that will improve or save lives, you spend years getting your product through clinical trials. And, finally, it’s approved by the U.S. Food and Drug Administration. Now, your product is ready to launch. But one major issue highlighted at a panel discussion […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The Innovation Forum at the Biotech 2011 conference in Philadelphia this week sought to put scientists and early stage startups from universities and incubators in the region in front of investors and alongside other, more mature startups to provide opportunities for investment and partnerships. Judith Sheft, associate vice president for technology and development at the […]
Kevin Buchi, the head of global branded products for Teva Pharmaceutical Industries (NASDAQ: TEVA), and Dr. Michael Rosenblatt, chief medical officer for Merck (NYSE: MRK), shared their views of the biotechnology and pharmaceutical industries and ways to improve innovation at Biotech 2011 this week. There were similar themes running through each man’s speech: Despite extending […]
New Jersey Lt. Gov. Kim Guadagno, by her own admission, was not subtle when she took center stage at the Biotech 2011 conference in Philadelphia to drum up business for her home state. She gave a speech layered with assurances of tax incentives and tax deductions to lure businesses. She even left her cell phone […]
The challenge of identifying and establishing financing for early and mid-stage companies is forcing companies to be more creative and making the series of panel discussions on the subject at Biotech 2011 in Philadelphia a high priority as companies and investors fleshed out what some of those structures look like. “Funding is patchwork,” said Al […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.